RxDoctor Payments Data

Richard Kim

Allergy & Immunology · Wilmington, DENPI 1831134170

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.3%), consulting fees and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Incyte Corporation at 42.5% of the total. Reporting peaked in 2019 at $2,290 and has fallen 92.0% since, to $184 in 2025.

$4,336in general payments, 2019–2025

Across 116 payments — averaging $37.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$2K
  • AstraZeneca$614
  • GSK$398
  • Regeneron Healthcare Solutions, Inc.$282
  • Mallinckrodt Hospital Products Inc.$184
  • Pfizer$153
  • plus $860 from 14 others

What the payments were for

  • Consulting fees$1,84543%
  • Food & beverage$2,48557%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy & immunology providers in Delawareto place this figure against a meaningful peer group, so we don't.

Other allergy & immunology in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →